Erratum to: Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
Crossref DOI link: https://doi.org/10.1007/s12325-017-0539-2
Published Online: 2017-05-26
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ohki, Takamasa http://orcid.org/0000-0003-4275-468X
Kondo, Mayuko
Karasawa, Yuki
Kawamura, Satoshi
Maeshima, Shuuya
Kojima, Kentaro
Seki, Michiharu
Toda, Nobuo
Shioda, Yoshinobu
Tagawa, Kazumi
Text and Data Mining valid from 2017-05-26
Article History
First Online: 26 May 2017